Synthesis of Silver Nanoparticles for Antibacterial Activity against Staphylococcus Aureus and Escherichia Coli
In Recent year's medication obstruction is a quickly developing issue over the whole world in the treatment of infectious diseases. The widespread use of broad-spectrum antibiotics produced antibiotic resistance for many human bacterial pathogens. Anyway right now, nanotechnology research has been engaging more in restorative businesses with various advantages because of the way that surface area to volume proportion of Nanoparticles is quite large. In this exploration work, Silver Nanoparticles (AgNPs) are prepared by using a reducing agent like sodium borohydride and capping agent polyvinylpyrolidine.
The AgNPs were set up by the chemical reduction method. Nanotechnology has its own importance it eventually reduce dose and also have a superior bioavailability than larger particles. The prepared AgNPs were subjected to characterization like particle size, X-Ray diffraction. In addition, the AgNPs drawing much interest in account of their powerful antibacterial movement. The antibacterial activity of AgNPs checked against the bacterial culture of Staphylococcus Aureus and E, coli. The zone of inhibition AgNPs was checked against both microorganisms. The results of this study demonstrate antibacterial activity of AgNPs against the bacterial culture of Staphylococcus Aureus and E, coli.
1. Patra J , et al , (2018) Nano based drug delivery systems: recent developments and future prospects, “J Nanobiotechnology. 2018; 16: 71. . doi: 10.1186/s12951-018-0392-8
2. Shinde N., et al, (2012). Nanoparticles: Advances in Drug Delivery Systems. Research Journal of Pharmaceutical, Biological and Chemical Sciences, Volume (3) Issue 1,922
3. S. Iravani ,et al (2014) Synthesis of AgNPs: chemical, physical and biological methods,” Res Pharm Sci. 2014 Nov-Dec; 9(6): 385–40
4. Dhrisya Chenthamara, et al(2019) Therapeutic efficacy of nanoparticles and routes of administration Biomater Res v.23; 2019 doi: 10.1186/s40824-019-0166-x
5. Linlin Wang et al (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future, “Int J Nanomedicines. 2017; 12:1227–1249. doi: 10.2147/IJN.S121956
6. Franci G et al. (2015) “AgNPs as potential antibacterial agents, ‘Molecules. 2015, May 18; 20(5):8856-74.
7. Sang Hun Lee1 et al. (2019) AgNPs: Synthesis and Application for Nanomedicine, “Int J Mol Sci.; 20(4): 865
8. Tikam C, et al (2016) “Mechanistic Basis of Antimicrobial Actions of AgNPs Front ‘Microbial. Vol 7: 1831.
9. Jaya Jain et al (2009) “AgNPs in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use, “Molecular Pharmaceutical, Vol. 6, P.N. 5
10. Chengzhu Liao, et al (2019), “Bactericidal and Cytotoxic Properties of AgNPs, “ International Journal Molecular Sci. Jan; 20(2): 449.
11. Linlin Wang, et al (2017)), “The antimicrobial activity of nanoparticles: present situation and prospects for the future, “International Journal of Nanomedicines.; 12: 1227–1249
12. Mamun Ur Rashid et al (2013) , ”Synthesis of Silver Nano Particles (Ag-NPs) and their uses for Quantitative Analysis of Vitamin C Tablets, “Dhaka Univ. J. Pharm,. Sci. 12(1): 29-33
13. G. Suriati et al (2013) synthesis of AgNPs by chemical reduction method: effect of reducing agent and surfactant concentration, “International Journal of Automotive and Mechanical Engineering (IJAME) , Volume 10, pp. 1920-1927, July-December 2014 DOI: http://dx.doi.org/10.15282/ijame.10.2014.9.0160 1920
14. Biswas P., et al, (2015). Research article effects and applications of AgNPs in different fields. International Journal of Recent Scientific Research, Vol. 6, Issue- 8, 5880-5883
15. Natsuki J., et al, (2015). A Review of AgNPs: synthesis methods, International Journal of Materials Science and Applications, 4(5),325-332
16. Naheed Ahmad et al (2012), Green Synthesis of AgNPs Using Extracts of Ananas comosus , Vol. 2 No. 4 (2012) , Article ID: 24781 ,7 pages DOI:10.4236/gsc.2012.24020
17. Sharma R. et al (2017) . Determination of defect density, crystallite size and number of graphene layers in graphene analogues using X-ray diffraction and Raman spectroscopy , “Indian Journal of Pure & Applied Physics Vol. 55, pp. 625-629
18. Desai L. et al (2012) , “Distribution of AgNPs: UV-Visible Spectroscopic Assessment” Nanoscience and Nanotechnology Letters Vol. 4, 30–34, 2012
19. Adriana Val´erio et al (2019) Usage of Scherrer’s formula in X-ray diffraction analysis of size distribution in systems of monocrystalline nanoparticles , arXiv:1911.00701v1 [cond-mat.mtrl-sci]
20. Cameron F. Holder and Raymond E. Schaak, “ACS Nano 2019 13 (7), 7359-7365 ,DOI: 10.1021/acsnano.9b05157
21. Franci G et al. “AgNPs as potential antibacterial agents, ‘Molecules. 2015, May 18;20(5):8856-74.
22. Blessing Atim et al, ‘Metal-Based Nanoparticles for the Treatment of Infectious Diseases, “Molecules 2017, 22, 1370
23. Tikam C et al (2016) “Mechanistic Basis of Antimicrobial Actions of AgNPs Front ‘Microbiol.; 7: 1831
24. Patral J et al, “Antibacterial Activity and Synergistic Antibacterial Potential of Biosynthesized AgNPs against Foodborne Pathogenic Bacteria along with its Anticandidal and Antioxidant Effects Front. “Microbial., 15 February 2017
25. Singh A et al, “ Biological and Physical Applications of AgNPs with Emerging Trends of Green Synthesis, “Engineered Nanomaterials - Health and Safety
26. Parvekar P. et al, “The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of AgNPs against Staphylococcus Aureus, Biomaterial Investigation in Dentistry, Tailor and Fransis.vol7 2020
27. Richard J Fair, et al (2014), ‘Antibiotics and Bacterial Resistance in the 21st Century, “Perspective in Medicinal Chemistry, 6: 25–64. Published online doi: 10.4137/PMC.S14459
28. Alem HF et al,(2011) “ Formulation and evaluation of AgNPs as antibacterial and antifungal agents with a minimal cytotoxic effect, “International Journal of Drug Delivery, 3 (2011) 293-304
29. O’Connor, K et al, (2005) “Formulation and evaluation of AgNPs as antibacterial and antifungal agents, Drug Discovery. 4, 1005-1014.
30. Bulmer, C. et al (2012) Production and characterization of novel chitosan nanoparticles for controlled release of rHu-Erythropoietin. Biochemical Engineering Journal, 68, 61–69.
31. T. Theivasanthi et al (2009), Anti-bacterial Studies of AgNPs ,Advances in Biological Research, 3 (3-4), 89-95.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).